O. Maíz

TL;DR: In this article, the authors conducted a multicenter study of patients with JIA-associated uveitis that was refractory to conventional immunosuppressive drugs and anti-tumor necrosis factor (anti-TNF) agents.

TL;DR: Anti-TNF-α therapy is effective and relatively safe in refractory BD uveitis and the best-corrected visual acuity and the suppression load also showed significant improvement.

TL;DR: The microbiome analysis combined with serum metabolomics can shed new light onto the pathogenesis of fibromyalgia and propose several molecules as potential biomarkers that can be used to evaluate the current diagnostic criteria.

TL;DR: Anti-TNF-α therapy is effective in sarcoid uveitis patients refractory to conventional immunosuppressive therapy and a substantial reduction in prednisone dose despite having failed standard therapy is observed.

TL;DR: CZP can be an effective alternative in refractory uveitis and achieve quiescence with CZP, and is well tolerated by patients with prior failure to other anti-TNF-α.